Sumol+Compal SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Sumol+Compal SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C10257
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポルトガル
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sumol+Compal SA – Strategy, SWOT and Corporate Finance Report
Summary

Sumol+Compal SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sumol+Compal SA (Sumol+Compal) is a beverage company based in Portugal. The company distributes, produces, and markets canned vegetables, tomato derivatives, juice and nectars, iced teas, chilled juices, and smoothies. It also produces carbonated and non-carbonated fruit-flavor beverages, beer, soft drinks, mineral and spring water, nutritional drinks and still fruit drinks. Sumol+Compal also produce and distribute products of PepsiCo in Portugal. The company operates through a network of distribution centers in Portugal and sells its products in several countries. It markets products across Africa, the Americas, Asia and Oceania, and Europe. Sumol+Compal is headquartered in Carnaxide, Portugal.

Scope

- Detailed information on Sumol+Compal SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sumol+Compal SA in the form of a SWOT analysis
- An in-depth view of the business model of Sumol+Compal SA including a breakdown and examination of key business segments
- Intelligence on Sumol+Compal SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sumol+Compal SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sumol+Compal SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sumol+Compal SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sumol+Compal SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Sumol+Compal SA: Company Overview 6
Sumol+Compal SA: Overview and Key Facts 6
Sumol+Compal SA: Overview 6
Sumol+Compal SA: Key Facts 6
Sumol+Compal SA: Key Employees 7
Sumol+Compal SA: Key Employee Biographies 8
Sumol+Compal SA: Major Products and Services 9
Sumol+Compal SA: Company History 10
Sumol+Compal SA: Management Statement 12
Sumol+Compal SA: Locations and Subsidiaries 13
Sumol+Compal SA: Key Competitors 14
Sumol+Compal SA: Company Analysis 15
Sumol+Compal SA: Business Description 15
Sumol+Compal SA: SWOT Analysis 17
Sumol+Compal SA: SWOT Overview 17
Sumol+Compal SA: Strengths 17
Sumol+Compal SA: Weaknesses 18
Sumol+Compal SA: Opportunities 18
Sumol+Compal SA: Threats 18
Appendix 20
Contact Us 20
Methodology 20
About MarketLine 21

List of Tables
Table 1: Sumol+Compal SA: Key Facts
Table 2: Sumol+Compal SA: Key Employees
Table 3: Sumol+Compal SA: Company History
Table 4: Sumol+Compal SA: Locations and Subsidiaries
Table 5: Sumol+Compal SA: Key Competitors



★海外企業調査レポート[Sumol+Compal SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Northwest Biotherapeutics Inc (NWBO):医療機器:M&Aディール及び事業提携情報
    Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer. The company by utilizing its proprietary technology platform, DCVax, developed a robust pipeline of therapeutic product candidates. DCVax is …
  • Altri SGPS SA (ALTR):企業の財務・戦略的SWOT分析
    Altri SGPS SA (ALTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Precision System Science Co Ltd (7707):企業の財務・戦略的SWOT分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company offers products such as automated nucleic acid isolation system, large sample volume nucleic acid extracti …
  • Infratil Ltd (IFT):電力:M&Aディール及び事業提携情報
    Summary Infratil Limited (Infratil) is involved in providing energy, transportation and infrastructure services. The company operates through trustpower, Australian energy, direct connect, Perth energy, Tilt Renewables, Wellington Airport, NZ bus, snapper, infratil property, Metlifecare, RetireAustr …
  • LegoChem Biosciences Inc (141080):企業の財務・戦略的SWOT分析
    Summary LegoChem Biosciences Inc (LCB) is a bio pharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of anti …
  • Rexnord Corp (RXN):企業の財務・戦略的SWOT分析
    Rexnord Corp (RXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Rural Bank Limited
    Rural Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Rural Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • 3M Health Information Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary 3M Health Information Systems Inc (3M HIS), a subsidiary of 3M Co, is a software and consulting services provider. The company offers healthcare technology, software and consulting services. Its services are designed for clinical documentation improvement, computer-assisted coding, mobile ph …
  • ESAB Holdings Ltd:企業の戦略・SWOT・財務情報
    ESAB Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary ESAB Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Mirabilis Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Mirabilis Medical Inc (Mirabilis Medical) is a medical device company that develops a non-invasive therapeutic ultrasound platform for the treatment of uterine fibroids in women. The company offers platform that targets symptoms of uterine fibroids such as pain, abnormal bleeding, pregnancy …
  • Biocad:製薬・医療:M&Aディール及び事業提携情報
    Summary Biocad is a biotechnology company that conducts research and development services. The company develops, manufactures and distributes generic pharmaceutical products. It develops products in urology, gynecology, dermatology, oncology, hematology, autoimmune diseases and infectious diseases t …
  • Olympus Corporation:企業の戦略・SWOT・財務情報
    Olympus Corporation - Strategy, SWOT and Corporate Finance Report Summary Olympus Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tele2 AB (TEL2 B):企業の財務・戦略的SWOT分析
    Tele2 AB (TEL2 B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Visioneering Technologies Inc (VTI):企業の製品パイプライン分析2018
    Summary Visioneering Technologies Inc (VTI) is a medical device company that offers ophthalmic solutions. The company develops a portfolio of technologies to address eye care issues such as presbyopia, myopia and astigmatism. Its technology includes myopia correction technology, silicone hydrogel ma …
  • Take-Two Interactive Software, Inc.
    Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report Summary Take-Two Interactive Software, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Glenmark Pharmaceuticals Limited:企業のM&A・事業提携・投資動向
    Glenmark Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Glenmark Pharmaceuticals Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on merge …
  • TSO3 Inc (TOS):企業の財務・戦略的SWOT分析
    TSO3 Inc (TOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Parker Institute for Cancer Immunotherapy:製薬・医療:M&Aディール及び事業提携情報
    Summary Parker Institute for Cancer Immunotherapy (Parker Institute), a subsidiary of The Parker Foundation is a nonprofit public benefit corporation which focuses on the development of immune therapies for the treatment of cancer. The institute coordinates together the scientists, nonprofits, acade …
  • Uranium Energy Corp:企業の戦略・SWOT・財務分析
    Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Uranium Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • CITIC Securities Company Limited:戦略・SWOT・企業財務分析
    CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report Summary CITIC Securities Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆